-+ 0.00%
-+ 0.00%
-+ 0.00%

RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares

PUBT·07/24/2026 01:23:15
Listen to the news
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares
  • RA Capital Management, a director and 10% owner of Artiva Biotherapeutics, reported open-market purchases totaling 264,586 common shares.
  • Purchases were reported at weighted average prices of USD 9.55, USD 9.93, USD 9.96.
  • Beneficial ownership rose to 17,242,483 common shares held indirectly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000791), on July 23, 2026, and is solely responsible for the information contained therein.